These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 15286712)

  • 1. Comparable transforming capacities and differential gene expression patterns of variant FUS/CHOP fusion transcripts derived from soft tissue liposarcomas.
    Schwarzbach MH; Koesters R; Germann A; Mechtersheimer G; Geisbill J; Winkler S; Niedergethmann M; Ridder R; Buechler MW; von Knebel Doeberitz M; Willeke F
    Oncogene; 2004 Sep; 23(40):6798-805. PubMed ID: 15286712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of TLS/FUS-CHOP fusion transcripts in a case of oral liposarcoma.
    Rivero ER; Mesquita RA; de Sousa SC; Nunes FD
    Ann Diagn Pathol; 2006 Feb; 10(1):36-8. PubMed ID: 16414544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FUS/TLS-CHOP chimeric transcripts in liposarcoma tissues.
    Yang X; Nagasaki K; Egawa S; Maruyama K; Futami H; Tsukada T; Yokoyama R; Beppu Y; Fukuma H; Shimoda T
    Jpn J Clin Oncol; 1995 Dec; 25(6):234-9. PubMed ID: 8523819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chimeric TLS/FUS-CHOP gene expression and the heterogeneity of its junction in human myxoid and round cell liposarcoma.
    Kuroda M; Ishida T; Horiuchi H; Kida N; Uozaki H; Takeuchi H; Tsuji K; Imamura T; Mori S; Machinami R
    Am J Pathol; 1995 Nov; 147(5):1221-7. PubMed ID: 7485386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogenic transformation and inhibition of adipocytic conversion of preadipocytes by TLS/FUS-CHOP type II chimeric protein.
    Kuroda M; Ishida T; Takanashi M; Satoh M; Machinami R; Watanabe T
    Am J Pathol; 1997 Sep; 151(3):735-44. PubMed ID: 9284822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic impact of P53 status, TLS-CHOP fusion transcript structure, and histological grade in myxoid liposarcoma: a molecular and clinicopathologic study of 82 cases.
    Antonescu CR; Tschernyavsky SJ; Decuseara R; Leung DH; Woodruff JM; Brennan MF; Bridge JA; Neff JR; Goldblum JR; Ladanyi M
    Clin Cancer Res; 2001 Dec; 7(12):3977-87. PubMed ID: 11751490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of FUS-CHOP fusion transcripts in different types of soft tissue liposarcoma and their diagnostic implications.
    Willeke F; Ridder R; Mechtersheimer G; Schwarzbach M; Duwe A; Weitz J; Lehnert T; Herfarth C; von Knebel Doeberitz M
    Clin Cancer Res; 1998 Jul; 4(7):1779-84. PubMed ID: 9676855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the FUS-CHOP fusion protein in primary mesenchymal progenitor cells gives rise to a model of myxoid liposarcoma.
    Riggi N; Cironi L; Provero P; Suvà ML; Stehle JC; Baumer K; Guillou L; Stamenkovic I
    Cancer Res; 2006 Jul; 66(14):7016-23. PubMed ID: 16849546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liposarcoma initiated by FUS/TLS-CHOP: the FUS/TLS domain plays a critical role in the pathogenesis of liposarcoma.
    Pérez-Losada J; Sánchez-Martín M; Rodríguez-García MA; Pérez-Mancera PA; Pintado B; Flores T; Battaner E; Sánchez-Garćia I
    Oncogene; 2000 Dec; 19(52):6015-22. PubMed ID: 11146553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the CHOP breakpoints and fusion transcripts in myxoid liposarcomas with the 12;16 translocation.
    Panagopoulos I; Mandahl N; Ron D; Höglund M; Nilbert M; Mertens F; Mitelman F; Aman P
    Cancer Res; 1994 Dec; 54(24):6500-3. PubMed ID: 7987849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fusion of the EWS and CHOP genes in myxoid liposarcoma.
    Panagopoulos I; Höglund M; Mertens F; Mandahl N; Mitelman F; Aman P
    Oncogene; 1996 Feb; 12(3):489-94. PubMed ID: 8637704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of TLS/FUS-CHOP fusion transcripts in myxoid and round cell liposarcomas by nested reverse transcription-polymerase chain reaction using archival paraffin-embedded tissues.
    Hisaoka M; Tsuji S; Morimitsu Y; Hashimoto H; Shimajiri S; Komiya S; Ushijima M
    Diagn Mol Pathol; 1998 Apr; 7(2):96-101. PubMed ID: 9785008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the FUS domain restores liposarcoma development in CHOP transgenic mice.
    Pérez-Mancera PA; Pérez-Losada J; Sánchez-Martín M; Rodríguez-García MA; Flores T; Battaner E; Gutiérrez-Adán A; Pintado B; Sánchez-García I
    Oncogene; 2002 Mar; 21(11):1679-84. PubMed ID: 11896599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel FUS/CHOP chimera in myxoid liposarcoma.
    Panagopoulos I; Mertens F; Isaksson M; Mandahl N
    Biochem Biophys Res Commun; 2000 Dec; 279(3):838-45. PubMed ID: 11162437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fusion of the dominant negative transcription regulator CHOP with a novel gene FUS by translocation t(12;16) in malignant liposarcoma.
    Rabbitts TH; Forster A; Larson R; Nathan P
    Nat Genet; 1993 Jun; 4(2):175-80. PubMed ID: 7503811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal expression of cell cycle regulators in FUS-CHOP carrying liposarcomas.
    Olofsson A; Willén H; Göransson M; Engström K; Meis-Kindblom JM; Stenman G; Kindblom LG; Aman P
    Int J Oncol; 2004 Nov; 25(5):1349-55. PubMed ID: 15492825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of genomic breakpoints in TLS-CHOP translocations in liposarcomas suggest the involvement of Translin and topoisomerase II in the process of translocation.
    Kanoe H; Nakayama T; Hosaka T; Murakami H; Yamamoto H; Nakashima Y; Tsuboyama T; Nakamura T; Ron D; Sasaki MS; Toguchida J
    Oncogene; 1999 Jan; 18(3):721-9. PubMed ID: 9989822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonality of multifocal myxoid liposarcoma: confirmation by analysis of TLS-CHOP or EWS-CHOP rearrangements.
    Antonescu CR; Elahi A; Healey JH; Brennan MF; Lui MY; Lewis J; Jhanwar SC; Woodruff JM; Ladanyi M
    Clin Cancer Res; 2000 Jul; 6(7):2788-93. PubMed ID: 10914725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fat-specific FUS-DDIT3-transgenic mice establish PPARgamma inactivation is required to liposarcoma development.
    Pérez-Mancera PA; Vicente-Dueñas C; González-Herrero I; Sánchez-Martín M; Flores-Corral T; Sánchez-García I
    Carcinogenesis; 2007 Oct; 28(10):2069-73. PubMed ID: 17468515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristic sequence motifs at the breakpoints of the hybrid genes FUS/CHOP, EWS/CHOP and FUS/ERG in myxoid liposarcoma and acute myeloid leukemia.
    Panagopoulos I; Lassen C; Isaksson M; Mitelman F; Mandahl N; Aman P
    Oncogene; 1997 Sep; 15(11):1357-62. PubMed ID: 9315104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.